ReviewVeterinary research communications2026
Veterinary antimicrobial resistance as a climate-sensitive emerging infectious disease: a paradigm shift in one health surveillance.
Review in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pharmacomicrobiomics-driven targeted drug delivery for precision microbiome modulation.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) is recognized as one of the most pressing global health threats, associated with more than one million deaths annually and disproportionately affecting vulnerable populations. Despite this burden, AMR is often conceptualized as a gradual crisis rather than as an emergent infectious process. This review explores the proposition that veterinary AMR may be better understood as a climate-sensitive emerging infectious disease (EID). Emerging evidence suggests that climatic variability, including heatwaves, floods, and droughts, can increase infection pressure in animals, influence antimicrobial use, and facilitate the environmental dissemination of resistance determinants. Current veterinary surveillance remains largely focused on resistance prevalence, with limited incorporation of climate-linked risk forecasting, leaving important gaps in preparedness. By synthesizing interdisciplinary evidence, this review outlines priorities for climate-aware veterinary stewardship, surveillance innovations linking genomic and environmental data, and policies that could elevate AMR to EID-level urgency. Such reframing has the potential to strengthen One Health resilience, protect animal welfare, and promote global health equity.
Indexed as
Identifiers
41521267What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.